Skip to main content

ORIGINAL RESEARCH article

Front. Public Health
Sec. Infectious Diseases: Epidemiology and Prevention
Volume 12 - 2024 | doi: 10.3389/fpubh.2024.1423004
This article is part of the Research Topic Combating Threats to Global Malaria Control View all articles

Development of a Plasmodium vivax malaria model for evaluating the effects of control strategies on the malaria burden in Democratic People's Republic of Korea

Provisionally accepted
Hye Seong Hye Seong 1Jiyeon Suh Jiyeon Suh 2Jun Y. Choi Jun Y. Choi 1Jeehyun Lee Jeehyun Lee 2Joon-Sup Yeom Joon-Sup Yeom 1*
  • 1 College of Medicine, Yonsei University, Seoul, Republic of Korea
  • 2 Yonsei University, Seoul, Seoul, Republic of Korea

The final, formatted version of the article will be published soon.

    Plasmodium vivax malaria has been one of the most troublesome diseases in the Democratic People's Republic of Korea (DPRK). Given that a majority of malaria cases are concentrated near the demilitarized zone, concerted elimination efforts from both the Republic of Korea (ROK) and DPRK are essential for a malaria-free Korean Peninsula. This study assessed the impact of rapid diagnostic tests (RDTs) and tafenoquine on malaria incidence in DPRK.We patterned the current model structure from the previously developed Plasmodium vivax malaria dynamic transmission model for ROK. Model parameters were adjusted using demographic and climate data from malaria-risk areas in DPRK, and the model was calibrated to annual malaria incidences from 2014-2018 in DPRK, as reported by the World Health Organization. Subsequently, we estimated the preventable malaria cases over a decade after introducing RDTs and tafenoquine compared to using microscopy alone and primaquine, respectively. Sensitivity analysis was performed to account for uncertainty in model parameters.When comparing RDTs to microscopy, a one-day reduction in diagnostic time due to the introduction of RDTs led to a reduction in malaria incidence by 26,235 cases (65.6%) over the next decade. With a two-day reduction, incidences decreased by 33,635 (84.1%). When comparing a single dose of tafenoquine with a 14-day primaquine regimen, the former prevented 1,222 (77.5%) relapse cases and 4,530 (11.3%) total cases over the years.The continuous and simultaneous implementation of RDTs and tafenoquine emerges as a potent strategy to considerably reduce malaria in DPRK.

    Keywords: Vivax malaria, mathematical modeling, RDT, Tafenoquine, DPRK

    Received: 25 Apr 2024; Accepted: 02 Aug 2024.

    Copyright: © 2024 Seong, Suh, Choi, Lee and Yeom. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Joon-Sup Yeom, College of Medicine, Yonsei University, Seoul, Republic of Korea

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.